Amelioration of pancreatic fat accumulation in Japanese type 2 diabetes patients treated with sodium-glucose cotransporter 2 inhibitors: a retrospective study.

Horii, Tomomi; Kozawa, Junji; Fujita, Shingo; Hosokawa, Yoshiya; Kimura, Takekazu; Fujita, Yukari; Tokunaga, Ayumi; Fukui, Kenji; Shimomura, Iichiro

Horii, Tomomi; Kozawa, Junji; Fujita, Shingo; Hosokawa, Yoshiya; Kimura, Takekazu; Fujita, Yukari; Tokunaga, Ayumi; Fukui, Kenji; Shimomura, Iichiro.

Affiliation

Horii T; Department of Metabolic Medicine Graduate School of Medicine Osaka University Suita Japan.
Kozawa J; Department of Metabolic Medicine Graduate School of Medicine Osaka University Suita Japan.
Fujita S; Department of Diabetes Care Medicine Graduate School of Medicine Osaka University Suita Japan.
Hosokawa Y; Department of Metabolic Medicine Graduate School of Medicine Osaka University Suita Japan.
Kimura T; Department of Metabolic Medicine Graduate School of Medicine Osaka University Suita Japan.
Fujita Y; Department of Metabolic Medicine Graduate School of Medicine Osaka University Suita Japan.
Tokunaga A; Department of Metabolic Medicine Graduate School of Medicine Osaka University Suita Japan.
Fukui K; Department of Community Medicine Graduate School of Medicine Osaka University Suita Japan.
Shimomura I; Department of Metabolic Medicine Graduate School of Medicine Osaka University Suita Japan.

Obes Sci Pract ; 7(3): 346-352, 2021 Jun.

Article de En | MEDLINE | ID: mdl-34123402

Mots clés

SGLT2 inhibitor; pancreatic fat; terms: type 2 diabetes

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Observational_studies Langue: En Journal: Obes Sci Pract Année: 2021 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google